Simplex Trading’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Simplex Trading’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-55,200	Closed	-$172K	–	10153
2023 Q2	$172K	Sell	55,200 -216,500	-80%	-$644K	﹤0.01%	4474
2023 Q1	$695K	Buy	+271,700	New	+$561K	﹤0.01%	2937
2022 Q4	–	Sell	-46,800	Closed	-$81K	–	10758
2022 Q3	$81K	Buy	46,800 +36,200	+342%	+$51.2K	﹤0.01%	5816
2022 Q2	$13K	Sell	10,600 -18,300	-63%	-$31.3K	﹤0.01%	8080
2022 Q1	$68K	Sell	28,900 -11,300	-28%	-$29.4K	﹤0.01%	6700
2021 Q4	$184K	Buy	+40,200	New	+$133K	﹤0.01%	5319

Other funds holding GRTX

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's GRTX Position: Q1 2024 in Review

Simplex Trading sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2024, closing a stake of 391 shares — an estimated $77 sold.

Simplex Trading first reported a position in GRTX in Q4 2021 and held it in 7 quarters. The position peaked at $496K in Q4 2021. 36 funds tracked by Wall St. Rank hold GRTX as of Q1 2024.

Simplex Trading reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Simplex Trading sold 391 Galera Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $77.
Simplex Trading first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Simplex Trading's Galera Therapeutics, Inc. Common Stock position peaked at $496K in Q4 2021.
36 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.